SK156395A3 - Peptid compounds, their manufacturing method and application - Google Patents

Peptid compounds, their manufacturing method and application Download PDF

Info

Publication number
SK156395A3
SK156395A3 SK1563-95A SK156395A SK156395A3 SK 156395 A3 SK156395 A3 SK 156395A3 SK 156395 A SK156395 A SK 156395A SK 156395 A3 SK156395 A3 SK 156395A3
Authority
SK
Slovakia
Prior art keywords
compounds
fvii
peptides
peptide
cells
Prior art date
Application number
SK1563-95A
Other languages
English (en)
Slovak (sk)
Inventor
Kjell S Sakariassen
Ross W Stephens
Original Assignee
Hafslund Nycomed As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939312601A external-priority patent/GB9312601D0/en
Application filed by Hafslund Nycomed As filed Critical Hafslund Nycomed As
Publication of SK156395A3 publication Critical patent/SK156395A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6437—Coagulation factor VIIa (3.4.21.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21021—Coagulation factor VIIa (3.4.21.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SK1563-95A 1993-06-18 1994-06-17 Peptid compounds, their manufacturing method and application SK156395A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB939312601A GB9312601D0 (en) 1993-06-18 1993-06-18 Peptides
GB9409335A GB9409335D0 (en) 1993-06-18 1994-05-10 Peptides
PCT/GB1994/001315 WO1995000541A1 (en) 1993-06-18 1994-06-17 Factor vii-derived peptides

Publications (1)

Publication Number Publication Date
SK156395A3 true SK156395A3 (en) 1996-06-05

Family

ID=26303086

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1563-95A SK156395A3 (en) 1993-06-18 1994-06-17 Peptid compounds, their manufacturing method and application

Country Status (15)

Country Link
US (1) US5962418A (no)
EP (1) EP0703923B1 (no)
JP (1) JPH08511794A (no)
CN (1) CN1125450A (no)
AT (1) ATE171950T1 (no)
CA (1) CA2164422A1 (no)
CZ (1) CZ334095A3 (no)
DE (1) DE69413817T2 (no)
DK (1) DK0703923T3 (no)
FI (1) FI956055A (no)
HU (1) HUT74873A (no)
NO (1) NO955067D0 (no)
NZ (1) NZ267453A (no)
SK (1) SK156395A3 (no)
WO (1) WO1995000541A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652332A (en) * 1993-03-12 1997-07-29 Xoma Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
GB9425380D0 (en) * 1994-12-15 1995-02-15 Nycomed Pharma As Peptides
GB9425381D0 (en) * 1994-12-15 1995-02-15 Nycomed Pharma As Peptides
US5837684A (en) * 1995-06-07 1998-11-17 Nycomed Imaging As Peptides
WO1999013063A1 (en) * 1997-09-09 1999-03-18 Nycomed Imaging As Factor vii fragments and analogs thereof and their use in the treatment of blood clottng disorders
WO1999013062A1 (en) * 1997-09-09 1999-03-18 Nycomed Imaging As Factors vii fragments and analogs thereof and their use in the treatment of blood clotting disorders
EP0987274A1 (en) 1998-09-15 2000-03-22 Hoechst Marion Roussel Deutschland GmbH Factor VIIa Inhibitors
WO2000077246A2 (en) * 1999-06-14 2000-12-21 Novo Nordisk A/S A METHOD FOR IDENTIFYING A DRUG CANDIDATE HAVING AN INHIBITORY ACTION ON FVII-TF ACTIVITY, AND FVIIa/TF ACTIVITY INHIBITING COMPOUNDS
WO2001001749A2 (en) 1999-07-02 2001-01-11 Genentech, Inc. FVIIa ANTAGONISTS
US7164002B2 (en) 2002-02-06 2007-01-16 Genentech, Inc. FVIIa antagonists
US20060257359A1 (en) * 2005-02-28 2006-11-16 Cedric Francois Modifying macrophage phenotype for treatment of disease
EP3402537B1 (en) 2016-01-15 2021-01-06 Rigshospitalet Quantitative pet imaging of tissue factor expression using 18f-labelled active site inhibited factor vii
EP3541432A4 (en) 2016-11-17 2020-08-05 Minerva Imaging ApS 177 LU MARKED FACTOR VII INHIBITED BY ACTIVE LOCATION

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5496927A (en) * 1985-02-04 1996-03-05 Merrell Pharmaceuticals Inc. Peptidase inhibitors
US4772587A (en) * 1985-04-16 1988-09-20 Suntory Limited Dipeptide derivative of fatty acid
US5087564A (en) * 1985-06-20 1992-02-11 Monsanto Company Release of recombinant peptides from polypeptides using V8 endopeptidase
US5047401A (en) * 1985-09-09 1991-09-10 Board Of Regents, The University Of Texas System Use of dipeptide alkyl esters to treat GVHD
AU4338689A (en) * 1988-09-23 1990-04-18 Corvas, Inc. Peptidyl inhibitors of the initiation of coagulation
EP0521873B1 (en) * 1990-01-29 1999-06-02 Zymogenetics, Inc. Anticoagulant proteins
DE4007902A1 (de) * 1990-03-13 1991-09-19 Behringwerke Ag Synthetische peptide, die sequenzen aus faktor viia enthalten und deren verwendung
CA2042295A1 (fr) * 1990-05-15 1991-11-16 Jacques Chauveau Derives de mediateurs endogenes, leurs sels, procede de preparation, applications, et compositions les renfermant
WO1993009804A1 (en) * 1991-11-18 1993-05-27 The Scripps Research Institute Serine protease derived-polypeptides and anti-peptide antibodies, systems and therapeutic methods for inhibiting coagulation

Also Published As

Publication number Publication date
EP0703923A1 (en) 1996-04-03
JPH08511794A (ja) 1996-12-10
NZ267453A (en) 1997-03-24
EP0703923B1 (en) 1998-10-07
US5962418A (en) 1999-10-05
WO1995000541A1 (en) 1995-01-05
DE69413817T2 (de) 1999-06-10
CA2164422A1 (en) 1995-01-05
AU6975594A (en) 1995-01-17
CZ334095A3 (en) 1996-07-17
CN1125450A (zh) 1996-06-26
DE69413817D1 (de) 1998-11-12
DK0703923T3 (da) 1999-06-21
HU9503593D0 (en) 1996-02-28
ATE171950T1 (de) 1998-10-15
FI956055A0 (fi) 1995-12-15
NO955067L (no) 1995-12-14
HUT74873A (en) 1997-02-28
AU691814B2 (en) 1998-05-28
NO955067D0 (no) 1995-12-14
FI956055A (fi) 1996-01-26

Similar Documents

Publication Publication Date Title
US5849690A (en) Anti-aggregatory peptides
JP2001504819A (ja) ウロキナーゼ型プラスミノゲンアクチベーターレセプターに結合する環状ペプチド
EP0703923B1 (en) Factor vii-derived peptides
WO1999013063A1 (en) Factor vii fragments and analogs thereof and their use in the treatment of blood clottng disorders
EP0500800B1 (en) Antihemostatic factor vii peptides
Martin et al. Synthesis and characterization of wild-type and variant. gamma.-carboxyglutamic acid-containing domains of factor VII
US5962408A (en) Disulphide-cyclo- H-Cys-Glu-Gln-Tyr-Cys-OH!, and its use in blood-clotting disorders
WO1995017420A1 (en) Peptide analogs of the activated platelet binding site on factor xi
US6703364B2 (en) Thrombin generation inhibitors
US5837684A (en) Peptides
AU6518300A (en) Peptide antagonists of factor VIIA
US5786330A (en) Peptide compounds which are therapeutically active in the cascade of blood coagulation, process for preparing them and pharmaceutical compositions containing them
AU691814C (en) Factor VII-derived peptides
AU607714B2 (en) Factor IX-peptides
US5948759A (en) Factor VII fragment 82-128 and its use in blood-clotting disorders
WO1999013062A1 (en) Factors vii fragments and analogs thereof and their use in the treatment of blood clotting disorders
CA1180006A (en) Therapeutically useful pseudopeptides, compositions containing the same and methods of preparation and use
IE902211A1 (en) The phospholipid binding domain of factor viii